# Pharmacokinetics, Safety, and Tolerability of Intramuscular 5-MeO-DMT in Healthy Volunteers

> **NCT05698095** · PHASE1 · COMPLETED · sponsor: **Usona Institute** · enrollment: 54 (actual)

## Conditions studied

- Pharmacokinetics
- Safety
- Tolerability

## Interventions

- **DRUG:** 5-methoxy-N,N-dimethyltryptamine succinate salt
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05698095
- **Lead sponsor:** Usona Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-12-27
- **Primary completion:** 2023-09-07
- **Final completion:** 2023-09-07
- **Target enrollment:** 54 (ACTUAL)
- **Last updated:** 2023-11-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05698095

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05698095, "Pharmacokinetics, Safety, and Tolerability of Intramuscular 5-MeO-DMT in Healthy Volunteers". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT05698095. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*